March 04, 2022
Vicore to host R&D Day
Media
March 03, 2022
Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
March 01, 2022
Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2021
February 28, 2022
Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer
February 28, 2022
Delays within FDA postpones CERAMENT G De Novo decision
February 25, 2022
Year-end report 2021
February 24, 2022
Q4 2021 General Market Overview
February 23, 2022
Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022
Priothera Enters Loan Agreement of €17.5 Million with the European Investment Bank
February 23, 2022
Vicore takes major step towards a clinical platform company targeting AT2R – new molecule ready for phase 1
